AAAAAA

   
Results: 1-13 |
Results: 13

Authors: SUTCH RJ QUME M BOWERY NG
Citation: Rj. Sutch et al., GABA UPTAKE REDUCED IN THE THALAMUS, BUT NOT THE CORTEX, OF AN ANIMAL-MODEL OF ABSENCE EPILEPSY, British Journal of Pharmacology, 122, 1997, pp. 275-275

Authors: QUME M FOWLER LJ
Citation: M. Qume et Lj. Fowler, EFFECT OF CHRONIC TREATMENT WITH THE GABA TRANSAMINASE INHIBITORS GAMMA-VINYL GABA AND ETHANOLAMINE O-SULFATE ON THE IN-VITRO GABA RELEASE FROM RAT HIPPOCAMPUS, British Journal of Pharmacology, 122(3), 1997, pp. 539-545

Authors: QUME M FOWLER LJ
Citation: M. Qume et Lj. Fowler, EFFECTS OF CHRONIC ORAL TREATMENT WITH GABA-TRANSAMINASE INHIBITORS ON THE GABA SYSTEM IN BRAIN, LIVER, KIDNEY, AND PLASMA OF THE RAT, Biochemical pharmacology, 52(9), 1996, pp. 1355-1363

Authors: QUME M MISRA A ZEMAN S MUTHU J CROSS AJ FRANCIS PT PROCTER AW NEARY D BOWEN DM
Citation: M. Qume et al., SEROTONERGIC PROFILES OF LOBAR ATROPHIES, Biochemical Society transactions, 23(4), 1995, pp. 600-600

Authors: QUME M MISRA A ZEMAN S BODDY JL CROSS AJ FRANCIS PT PROCTER AW MANN DMA BOWEN DM
Citation: M. Qume et al., NONSEROTONERGIC PROFILES OF LOBAR ATROPHIES, Biochemical Society transactions, 23(4), 1995, pp. 601-601

Authors: QUME M WHITTON PS FOWLER LJ
Citation: M. Qume et al., THE EFFECT OF CHRONIC TREATMENT WITH THE GABA TRANSAMINASE INHIBITORSGAMMA-VINYL-GABA AND ETHANOLAMINE-O-SULFATE ON THE IN-VIVO RELEASE OFGABA FROM RAT HIPPOCAMPUS, Journal of neurochemistry, 64(5), 1995, pp. 2256-2261

Authors: QUME M ZEMAN S FRANCIS PT PROCTER AW BOWEN DM
Citation: M. Qume et al., CHANGES IN CORTICAL 5-HT1(A), RECEPTOR FINDING IN LOBAR ATROPHIES (PICKS-DISEASE AND DEMENTIA OF THE FRONTAL-LOBE TYPE), British Journal of Pharmacology, 116, 1995, pp. 237-237

Authors: QUME M BOWERY NG FOWLER LJ
Citation: M. Qume et al., THE EFFECT OF 2-DAY, 8-DAY AND 21-DAY TREATMENT WITH GABA-T INHIBITORS ON GABA(A), GABA(B) AND FLUNITRAZEPAM BINDING TO RAT CRUDE SYNAPTIC-MEMBRANES, British Journal of Pharmacology, 116, 1995, pp. 391-391

Authors: QUME M MISRA A ZEMAN S STRATMANN GC WORTH C CROSS AJ FRANCIS PT PROCTER AW BOWEN DM
Citation: M. Qume et al., NEUROCHEMICAL PROFILES OF NON-ALZHEIMER NEURODEGENERATIVE DISORDERS, Neurobiology of aging, 15, 1994, pp. 190000120-190000120

Authors: BOWEN DM CHESSELL IP FRANCIS PT PROCTER AW QUME M WEBSTER MT
Citation: Dm. Bowen et al., IS IMPROVEMENT OF CHOLINERGIC TRANSMISSION THE CORRECT STRATEGY FOR ALZHEIMERS-DISEASE, Neurobiology of aging, 15, 1994, pp. 190000147-190000147

Authors: QUME M ZEMAN S STRATMANN GC WORTH C FRANCIS PT PROCTER AW BOWEN DM
Citation: M. Qume et al., A NEUROCHEMICAL STUDY OF NON-ALZHEIMER DEMENTIA, British Journal of Pharmacology, 112, 1994, pp. 210000031-210000031

Authors: DAVIES J QUME M HARRIS NC
Citation: J. Davies et al., PHARMACOLOGICAL CHARACTERIZATION OF EXCITATORY SYNAPTIC TRANSMISSION IN THE CAT RED NUCLEUS IN-VIVO, Brain research, 649(1-2), 1994, pp. 43-52

Authors: PROCTER AW FRANCIS PT HOLMES C WEBSTER MT QUME M STRATMANN GC DOSHI R MANN DMA HARRISON PJ PEARSON RCA BOWEN DM
Citation: Aw. Procter et al., BETA-AMYLOID PRECURSOR PROTEIN ISOFORMS SHOW CORRELATIONS WITH NEURONS BUT NOT WITH GLIA OF DEMENTED SUBJECTS, Acta Neuropathologica, 88(6), 1994, pp. 545-552
Risultati: 1-13 |